Nano- and microplastics: a comprehensive review on their exposure routes, translocation, and fate in humans.


Journal

NanoImpact
ISSN: 2452-0748
Titre abrégé: NanoImpact
Pays: Netherlands
ID NLM: 101676795

Informations de publication

Date de publication:
01 2023
Historique:
received: 24 05 2022
revised: 15 11 2022
accepted: 17 11 2022
pubmed: 26 11 2022
medline: 8 3 2023
entrez: 25 11 2022
Statut: ppublish

Résumé

Contamination of the environment with nano-and microplastic particles (NMPs) and its putative adverse effects on organisms, ecosystems, and human health is gaining increasing scientific and public attention. Various studies show that NMPs occur abundantly within the environment, leading to a high likelihood of human exposure to NMPs. Here, different exposure scenarios can occur. The most notable exposure routes of NMPs into the human body are via the airways and gastrointestinal tract (GIT) through inhalation or ingestion, but also via the skin due to the use of personal care products (PCPs) containing NMPs. Once NMPs have entered the human body, it is possible that they are translocated from the exposed organ to other body compartments. In our review article, we combine the current knowledge on the (1) exposure routes of NMPs to humans with the basic understanding of the potential (2) translocation mechanisms into human tissues and, consequently, their (3) fate within the human body. Regarding the (1) exposure routes, we reviewed the current knowledge on the occurrence of NMPs in food, beverages, personal care products and the air (focusing on indoors and workplaces) and found that the studies suggest an abundant presence of MPs within the exposure scenarios. The overall abundance of MPs in exposure matrices relevant to humans highlights the importance of understanding whether NMPs have the potential for tissue translocation. Therefore, we describe the current knowledge on the potential (2) translocation pathways of NMPs from the skin, GIT and respiratory systems to other body compartments. Here, particular attention was paid to how likely NMPs can translocate from the primary exposed organs to secondary organs due to naturally occurring defence mechanisms against tissue translocation. Based on the current understanding, we conclude that a dermal translocation of NMPs is rather unlikely. In contrast, small MPs and NPs can generally translocate from the GIT and respiratory system to other tissues. Thus, we reviewed the existing literature on the (3) fate of NMPs within the human body. Based on the current knowledge of the contamination of human exposure routes and the potential translocation mechanisms, we critically discuss the size of the detected particles reported in the fate studies. In some cases, the particles detected in human tissue samples exceed the size of a particle to overcome biological barriers allowing particle translocation into tissues. Therefore, we emphasize the importance of critically reading and discussing the presented results of NMP in human tissue samples.

Identifiants

pubmed: 36427812
pii: S2452-0748(22)00063-5
doi: 10.1016/j.impact.2022.100441
pii:
doi:

Substances chimiques

Microplastics 0
Plastics 0

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100441

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing interests.

Auteurs

Anja F R M Ramsperger (AFRM)

Animal Ecology I & BayCEER, University of Bayreuth, Bayreuth, Germany; Biological Physics, University of Bayreuth, Bayreuth, Germany.

Enrico Bergamaschi (E)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Marco Panizzolo (M)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Ivana Fenoglio (I)

Department of Chemistry, University of Turin, Turin, Italy.

Francesco Barbero (F)

Department of Chemistry, University of Turin, Turin, Italy.

Ruud Peters (R)

Wageningen Food Safety Research, Wageningen University & Research, Wageningen, the Netherlands.

Anna Undas (A)

Wageningen Food Safety Research, Wageningen University & Research, Wageningen, the Netherlands.

Sebastian Purker (S)

Institute of Safety and Risk Sciences (ISR), University of Natural Resources and Life Sciences, Vienna, Austria.

Bernd Giese (B)

Institute of Safety and Risk Sciences (ISR), University of Natural Resources and Life Sciences, Vienna, Austria.

Carina R Lalyer (CR)

Institute of Safety and Risk Sciences (ISR), University of Natural Resources and Life Sciences, Vienna, Austria.

Alba Tamargo (A)

Institute of Food Science Research (CIAL), CSIC-UAM, Madrid, Spain.

M Victoria Moreno-Arribas (MV)

Institute of Food Science Research (CIAL), CSIC-UAM, Madrid, Spain.

Hans-Peter Grossart (HP)

Plankton and Microbial Ecology, Leibniz Institute for Freshwater Ecology and Inland Fisheries (IGB), Berlin, Germany; Biochemistry and Biology, Potsdam University, Potsdam, Germany.

Dana Kühnel (D)

Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Germany.

Jana Dietrich (J)

Institute of Functional and Clinical Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Friedrich Paulsen (F)

Institute of Functional and Clinical Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Anani K Afanou (AK)

National Institute of Occupational Health, Oslo, Norway.

Shan Zienolddiny-Narui (S)

National Institute of Occupational Health, Oslo, Norway.

Stine Eriksen Hammer (S)

National Institute of Occupational Health, Oslo, Norway.

Torunn Kringlen Ervik (T)

National Institute of Occupational Health, Oslo, Norway.

Pål Graff (P)

National Institute of Occupational Health, Oslo, Norway.

Bendik C Brinchmann (BC)

National Institute of Occupational Health, Oslo, Norway; Section of Air Pollution and Noise, Department of Environment and Health, Norwegian Institute of Public Health, Oslo, Norway.

Karl-Christian Nordby (KC)

National Institute of Occupational Health, Oslo, Norway.

Håkan Wallin (H)

National Institute of Occupational Health, Oslo, Norway.

Matteo Nassi (M)

Ecamricert srl, Monte di Malo, Vicenza, Italy.

Federico Benetti (F)

Ecamricert srl, Monte di Malo, Vicenza, Italy.

Michela Zanella (M)

Ecamricert srl, Monte di Malo, Vicenza, Italy.

Julian Brehm (J)

Animal Ecology I & BayCEER, University of Bayreuth, Bayreuth, Germany.

Holger Kress (H)

Biological Physics, University of Bayreuth, Bayreuth, Germany.

Martin G J Löder (MGJ)

Animal Ecology I & BayCEER, University of Bayreuth, Bayreuth, Germany.

Christian Laforsch (C)

Animal Ecology I & BayCEER, University of Bayreuth, Bayreuth, Germany. Electronic address: Christian.laforsch@uni-bayreuth.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH